Zolgensma (Onasemnogene aberparvovec) - Important Safety Information from Novartis UK Limited as approved by the HPRA (16.02.2023)

Notice type: 3rd Party Publications

Date: 22/02/2023

Important Safety Information from Novartis UK Limited regarding ZOLGENSMA (Onasemnogene abeparvovec) - Fatal Cases of Acute Liver Failure

Important Safety Information – ZOLGENSMA (Onasemnogene abeparvovec)